Midatech Announces Proposed Sale of Midatech Pharma US Inc. (“MTP US”) to Kanwa Holdings, LP an affiliate of Barings LLC
September 27, 2018 07:00 ET
|
Midatech Pharma Plc
27 September 2018 Midatech Pharma PLC ("Midatech" or the "Company") Midatech Announces Proposed Sale of Midatech Pharma US Inc. (“MTP US”) to Kanwa Holdings, LP an affiliate of Barings LLC Total...
Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera™ Microsphere Technology
August 31, 2018 07:00 ET
|
Midatech Pharma Plc
31 August 2018 Midatech Pharma PLC("Midatech" or the "Company") Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera™...
Midatech Pharma US announces Co-Promotion Agreement with Bausch Health Companies Inc. for the Exclusive Right to Promote NeutraSal® to the Oncology Market in United States
July 23, 2018 07:11 ET
|
Midatech Pharma Plc
23 July 2018 Midatech Pharma PLC(“Midatech”, “Company” or “Group”) Midatech Pharma US announces Co-Promotion Agreement with Bausch Health Companies Inc. for the Exclusive Right to Promote NeutraSal®...
Midatech Pharma announces clinical pipeline update
May 18, 2016 02:00 ET
|
Midatech Pharma PLC
ABINGDON, England, May 18, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
Result of Annual General Meeting
May 11, 2016 12:44 ET
|
Midatech Pharma PLC
ABINGDON, England, May 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
Midatech Pharma announces positive pharmacokinetic data with Q-Octreotide
April 26, 2016 02:00 ET
|
Midatech Pharma PLC
ABINGDON, England, April 26, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH; Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products in...
Midatech achieves positive dosing data for OpsiSporin Uveitis programme
April 21, 2016 02:00 ET
|
Midatech Pharma PLC
ABINGDON, England, April 21, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
Midatech Pharma PLC (“Midatech” or the “Company”) Audited financial results for the year ended 31 December 2015
April 13, 2016 02:00 ET
|
Midatech Pharma PLC
Midatech will host a conference call and live Q&A session today (Wednesday 13 April 2016) at 1300 BST / 0800 EDT for analysts and investors to discuss the Annual Results. Dr Jim Phillips, Chief...
Midatech’s Commercial Launch of Zuplenz® (Ondansetron) Oral Soluble Film to Prevent Post-Operative, Chemotherapy and Radiation-Induced Nausea and Vomiting in US
April 11, 2016 02:00 ET
|
Midatech Pharma PLC
ABINGDON, England, April 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH); (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing...